A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease (SPIRR-CAD) - Rationale and design of a multicenter, randomized trial in depressed patients with CAD

Journal of Psychosomatic Research

Volumn 71, Issue 4, 2011, Pages 215-222

  Albus, Christian ^a   Beutel, Manfred E ^b   Deter, Hans Christian ^c   Fritzsche, Kurt ^d   Hellmich, Martin ^a   Jordan, Jochen ^e   Juenger, Jana ^f   Krauth, Christian ^g   Ladwig, Karl Heinz ^h   Michal, Matthias ^b   Mueck Weymann, Michael ⁱ   Petrowski, Katja ⁱ   Pieske, Burkert ^j   Ronel, Joram ^k   Soellner, Wolfgang ^l   Waller, Christiane ^g   Weber, Cora ^c   Herrmann Lingen, Christoph ^m  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e KERCKHOFF HEART CENTER   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h Helmholtz Zentrum Muenchen   (Germany)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l Dept of Psychosomatic Medicine and Psychotherapy   (Germany)

^m UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

more..

Author keywords

Coronary artery disease; Depression; Psychotherapy; Randomized controlled trial

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COGNITIVE THERAPY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUNSELING; DEPRESSION; FEMALE; HEALTH CARE UTILIZATION; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PSYCHODYNAMICS; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION;

ADOLESCENT; ADULT; AFFECT; AGED; CORONARY ARTERY DISEASE; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PSYCHOTHERAPY; RESEARCH DESIGN; RISK; RISK REDUCTION BEHAVIOR;

EID: 80052683633     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2011.02.013     Document Type: Article

References (68)

1. Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., et al. Prevalence of depression in survivors of acute myocardial infarction. Review of the evidence. J Gen Intern Med 2006, 21:30-38.
2. Herrmann-Lingen C., Buss U. Anxiety and depression in patients with coronary heart disease. Psychocardiology. A systematic review of the literature 2007, 125-154. American Psychological Association, Washington. J. Jordan, B. Barde, A.M. Zeiher (Eds.).
3. Ladwig K.H., Lederbogen F., Völler H., Albus C., Herrmann-Lingen C., Jordan J., et al. Positionspapier zur Bedeutung von psychosozialen Faktoren in der Kardiologie. Der Kardiologe 2008, 4:274-287.
4. Barth J., Schumacher M., Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004, 66:802-813.
5. Van Melle J., de Jonge P., Spijkerman T.A., Tjissen J.G.P., Ormel J., Van Veldhuisen D.J., et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events. Psychosom Med 2004, 66:814-822.
6. Nicholson A., Kuper H., Hemingway Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146538 participants in 54 observational studies. Eur Heart J 2006, 27:2763-2774.
7. Sorensen C., Friis-Hasche E., Haghfelt T., Bech P. Postmyocardial infarction mortality in relation to depression: a systematic critical review. Psychother Psychosom 2005, 74:69-80.
8. Frasure-Smith N., Lesperance F. Depression and cardiac risk: present status and future directions. Heart 2010, 96:173-176.
9. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., Kuzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005, 45:637-651.
10. Lichtman J.H., Bigger J.T., Blumenthal J.A., Frasure-Smith N., Kaufmann P.G., Lesperance F., et al. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee of the Council on Epidemiology and Prevention, and Interdisciplinary Council on quality of care and outcomes research. Circulation 2008, 118:1768-1775.
11. Graham I., Atar A., Borch-Johnsen, Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Eur J Cardiovasc Prev Rehabil 2007, 14:S1-S113.
12. Thombs B.D., De Jonge P., Coyne J.C., Whooley M.A., Frasure-Smith N., Mitchell A.J., et al. Depression screening and patient outcomes in cardiovascular care. A systematic review. JAMA 2008, 300:2161-2171.
13. Dowlati Y., Herrmann N., Swardfager W.L., Reim E.K., Lancetot K.L. Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Can J Psychiatry 2010, 55:91-99.
14. Rees K., Bennett P., West R., Davey Smith G., Ebrahim S. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev 2004, 2:CD002902.
15. Cuipers P., van Straten A., Bohlemeijer E., Hollon S.D., Andersson G. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010, 40:211-223.
16. Cuipers P., Smit F., Bohlmeijer E., Hollon S.D., Andersson G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic-study of publication bias. Br J Psychiatry 2010, 196:173-178.
17. Linden W., Phillips M.J., Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J 2007, 28:2972-2984.
18. Glassman A.H., O'Connor C.M., Calif R.M. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709. for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group.
19. Honig A., Kuyper A.M., Schene A.H., van Melle J.P., De Jonge P., Tulner D.M., et al. Treatment of post-myocardial infarction depressive disorder: a randomized placebo-controlled trial with mirtazapine. Psychosom Med 2007, 69:606-613.
20. Van Melle J.P., De Jonge P., Honig A., Schene A.H., Kuyper A.M.G., Crijns H.J.G.M., et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007, 190:460-466.
21. Lesperance F., Frasure-Smith N., Koszycki D. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367-369.
22. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289:3106-3116. Writing committee for the ENRICHD investigators.
23. Barth J., Paul J., Härter M., Bengel J. Inpatient psychotherapeutic treatment for cardiac patients with depression in Germany. GMS Psychosoc Med 2005, 2. Doc04 (20050323).
24. Davidson K.W., Rieckmann N., Clemow L., Schwartz J.E., Shimbo D., Medina V., et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms. Coronary psychosocial evaluation studies randomized controlled trial. Arch Int Med 2010, 7:600-608.
25. Lie I., Arnesen H., Sandvik L., Hamilton G., Bunch E.H. Effects of a home-based intervention program on anxiety and depression 6months after coronary artery bypass grafting: a randomized controlled trial. J Psychosom Res 2007, 63:411-418.
26. Rollman B.L., Belnap B.H., LeManger M.S., Mazumdar S., Houck P.R., Counihan P.J., et al. Telephone-delivered collaborative care for treating post-CABG depression. A randomized controlled trail. JAMA 2009, 302:2095-2103.
27. Freedland K.E., Skala J.A., Carney R.M., Rubin E.H., Lustman P.J., Davila-Roman V.G., et al. Treatment of depression after coronary artery bypass surgery. A randomized controlled trial. Arch Gen Psychiatry 2009, 66:387-396.
28. Driessen E., Cuipers P., de Maat S.C.M., Abbass A.A., de Jonghe F., Dekker J.J.M. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis. Clin Psychol Rev 2010, 30:25-36.
29. Denollet J., Schiffer A., Spek V. A general propensity to psychological distress affects cardiovascular outcomes. Evidence from research on the Type D (distressed) personality profile. Circ Cardiovasc Qual Outcomes 2010, 3:546-557.
30. Coyne J.C., Whiffen V.E. Issues in personality as diathesis for depression: the case of sociotrophy-dependence and autonomy-self-criticism. Psychol Bull 1995, 118:358-378.
31. Maxwell S.C., Delaney H.D. Bivariate median splits and spurious statistical significance. Psychol Bull 1993, 113:181-190.
32. Karlsson M.R., Edstroem-Pluess, Herld C., Henriksson P., Billing E., Wallen N.H. Effects of expanded cardiac rehabilitation on psychosocial status in coronary artery disease with focus on type d characteristics. J Behav Med 2007, 30:253-261.
33. Saab P.G., Bang H., Williams R.B., Powell L.H., Schneiderman N., Thoresen C., et al. The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. J Psychosom Res 2009, 67:45-56.
34. Moher D., Hopewell S., Schulz K.F., Montori V., Gotzsche P., Devereaux P.J., et al. Consort 2010 explanation and elaboration: updated guidelines for reporting parallel group randomized trials. BMJ 2010, 340:c896.
35. Albus Ch, Deter H.C., Fritzsche K., Jordan J., Jünger J., Ladwig K.H., et al. Feasibility of recruiting depressed patients with coronary artery disease for a randomized psychotherapy. Psychosom Med 2006, 68:A-50.
36. Herrmann C., Brand-Driehorst S., Kaminsky B., Leibing E., Staats H., Rüger U. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom Med 1998, 60:570-577.
37. Herrmann C., Brand-Driehorst S., Buss U., Rüger U. Effects of anxiety and depression on five-year mortality in 5057 patients referred for exercise testing. J Psychosom Res 2000, 48:455-462.
38. Fritzsche K., Albus C., Jordan J., Beutel M.E., Wiltink J., Herrmann-Lingen C., et al. Einzel- und Paarintervention für depressive Koronarpatienten. Therapiemanual, Qualitätssicherung und erste Erfahrungen im Rahmen einer randomisierten, kontrollierten Interventionsstudie. Psychotherapeut 2010, (online first). 10.1007/s00278-010-0783-2.
39. Williams V., Williams R.B. Life skills 1997, Times Books, New York.
40. Powell L.H. The Hook: a metaphor for gaining control of emotional reactivity. Heart and mind: the practice of cardiac psychology 1996, 313-327. American Psychological Association, Washington DC. R. Allan, S. Scheidt (Eds.).
41. Gidron Y., Davidson K., Bata I. The short-term effects of a hostility-reduction intervention on male coronary heart disease patients. Health Psychol 1999, 18:416-420.
42. Bishop G., Kaur M., Tan V., Chua Y., Liew S., Mak K. Psychosocial skills training reduces stress reactivity, resting heart rate and psychosocial risk in patients undergoing coronary artery bypass grafting. Am Heart J 2005, 150:602-609.
43. Barber J., Crits-Christoph P. Development of a therapist adherence and competence rating scale for supportive-expressive dynamic psychotherapy. Psychother Res 1996, 6:81-94.
44. Tschuschke V., Hess H., MacKenzie R. Der Gruppenklima-Fragebogen (GCQ-S) - Methodik und Anwendung eines Meßinstruments zum Gruppenerleben. Gruppenpsychotherapie Gruppendynamik 1990, 26:340-359.
45. Herrmann C., Buss U., Snaith R.P. HADS-D. Hospital Anxiety and Depression Scale, Deutsche Version 1995, Hans Huber, Bern.
46. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997, 42:17-41.
47. Barth J., Martin C.R. Factor structure of the Hospital Anxiety and Depression Scale (HADS) in German coronary heart disease patients. Health Qual Life Outcomes 2005, 16:15.
48. Hinz A., Zweynert U., Kittel J., Igl W., Schwarz R. Veränderungsmessung mit der Hospital Anxiety and Depression Scale (HADS): Änderungssensitivität und Änderungsreliabilität. Psychother Psychosom Med Psychol 2009, 59:394-400.
49. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
50. Wittchen H.U., Zaudig M., Fydrich T. Strukturiertes klinisches Interview für DSM-IV (SKID I und SKID-II) 1997, Hogrefe, Göttingen.
51. Denollet J. DS-14: standard assessment of negative affectivity, social inhibition, and type-D personality. Psychosom Med 2005, 67:89-97.
52. Grande G., Jordan J., Kümmel M., Struwe C., Schubmann R., Schulze F., et al. Evaluation der deutschen Typ D-Skala (DS14) und Prävalenz der Typ D-Persönlichkeit bei kardiologischen und psychosomatischen Patienten sowie Gesunden. Psychother Psychosom Med Psychol 2004, 54:413-422.
53. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
54. Bullinger M., Kirchberger I. SF-36. Fragebogen zum Gesundheitszustand 1996, Göttingen, Hogrefe.
55. Task Force of the European Society of Cardiology, The North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996, 17:354-381.
56. Appels A., Bär F.W., Bär J., Bruggeman C., de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000, 62:601-605.
57. Ridker P.M., Morrow D.A. C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003, 21:315-325.
58. Schnabel R., Rupprecht H.J., Lackner K.J., Lubos E., Bickel C., Meyer J., et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005, 26:241-249.
59. Von Känel R., Mills P.J., Fainman C., Dimsdale J.E. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?. Psychosom Med 2001, 63:531-544.
60. Krause M.S., Lutz W. What should be used for baselines against which to compare treatments' effectiveness?. Psychother Res 2009, 19:358-367.
61. National collaborating center for mental health. National institute for health, clinical excellence (NICE) Depression: the treatment and management of depression in adults (update). NICE clinical guidance 90 2009, http://www.nice.org.uk/CG90.
62. Carney R.M., Freedland K.E., Stein P.K., Skala J.A., Hoffman P., Jaffe A.S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000, 62:639-647.
63. Smith J.K., Dykes R., Douglas J.E., Krishnaswamy G., Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA 1999, 281:1722-1777.
64. Frasure-Smith N., Lespérance F., Prince R.H., Verrier P., Garber R.A., Juneau M., et al. Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 1997, 350:473-479.
65. Burell G., Granlund B. Women's hearts need special treatment. Int J Behav Med 2002, 9:228-242.
66. Schneiderman N., Saab P.G., Catellier D.J., Powell L.H., DeBusk R.F., Williams R.B., et al. Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom Med 2004, 66:475-483.
67. Sen S., Burmeister M., Ghosh D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am J Med Genet B Neuropsychiatr Genet 2004, 127:85-89.
68. Baghai T.C., Schule C., Zwanzger P., Minov C., Zill P., Ella R., et al. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci Lett 2002, 328:299-303.